Adverse drug reaction update.
Increasing numbers of articles on adverse drug reactions are published in a wide range of medical journals. To help keep you up-to-date with the latest advances worldwide on all aspects of adverse drug reactions, this section of the journal brings you information selected from the drug safety alerting service Reactions Weekly. The following reports are selected from the latest issues, summarizing the most important clinical studies, adverse reaction news, and expert opinion pieces published across a broad range of literature sources.
D000328:Adult; D016907:Adverse Drug Reaction Reporting Systems; D001569:Benzodiazepines; D016642:Bupropion / Q000009:adverse effects; D002243:Carbolines / Q000009:adverse effects; D002648:Child; D015251:Epirubicin / Q000009:adverse effects; D005060:Europe; D006801:Humans; D000077152:Olanzapine; D010890:Pirenzepine / Q000009:adverse effects / Q000031:analogs & derivatives*; D011753:Pyrones / Q000009:adverse effects; D013881:Thioridazine / Q000009:adverse effects; D020888:Vigabatrin / Q000009:adverse effects
D002243:Carbolines; D011753:Pyrones; D016642:Bupropion; D001569:Benzodiazepines; C090840:alosetron; D010890:Pirenzepine; D015251:Epirubicin; D020888:Vigabatrin; D013881:Thioridazine; D000077152:Olanzapine; C011889:kavain